Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

1.

A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder.

Simpson HB, Foa EB, Liebowitz MR, Ledley DR, Huppert JD, Cahill S, Vermes D, Schmidt AB, Hembree E, Franklin M, Campeas R, Hahn CG, Petkova E.

Am J Psychiatry. 2008 May;165(5):621-30. doi: 10.1176/appi.ajp.2007.07091440. Epub 2008 Mar 3.

2.

Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.

Tundo A, Salvati L, Busto G, Di Spigno D, Falcini R.

J Clin Psychiatry. 2007 Oct;68(10):1552-6.

PMID:
17960971
3.

Statistical choices can affect inferences about treatment efficacy: a case study from obsessive-compulsive disorder research.

Simpson HB, Petkova E, Cheng J, Huppert J, Foa E, Liebowitz MR.

J Psychiatr Res. 2008 Jul;42(8):631-8. Epub 2007 Sep 24.

4.

Response versus remission in obsessive-compulsive disorder.

Simpson HB, Huppert JD, Petkova E, Foa EB, Liebowitz MR.

J Clin Psychiatry. 2006 Feb;67(2):269-76.

PMID:
16566623
5.

Biological therapies for obsessive-compulsive disorder.

Fallon BA, Mathew SJ.

J Psychiatr Pract. 2000 May;6(3):113-28.

PMID:
15990479
6.

Standard criteria for relapse are needed in obsessive-compulsive disorder.

Simpson HB, Franklin ME, Cheng J, Foa EB, Liebowitz MR.

Depress Anxiety. 2005;21(1):1-8.

PMID:
15806597
7.

Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder.

Foa EB, Liebowitz MR, Kozak MJ, Davies S, Campeas R, Franklin ME, Huppert JD, Kjernisted K, Rowan V, Schmidt AB, Simpson HB, Tu X.

Am J Psychiatry. 2005 Jan;162(1):151-61.

PMID:
15625214
8.

Post-treatment effects of exposure therapy and clomipramine in obsessive-compulsive disorder.

Simpson HB, Liebowitz MR, Foa EB, Kozak MJ, Schmidt AB, Rowan V, Petkova E, Kjernisted K, Huppert JD, Franklin ME, Davies SO, Campeas R.

Depress Anxiety. 2004;19(4):225-33.

PMID:
15274171
9.

Long-term efficacy of exposure and ritual prevention therapy and serotonergic medications for obsessive-compulsive disorder.

Hembree EA, Riggs DS, Kozak MJ, Franklin ME, Foa EB.

CNS Spectr. 2003 May;8(5):363-71, 381.

PMID:
12766692
10.

The comparative effectiveness of treatments for obsessive-compulsive disorder.

Greist JH.

Bull Menninger Clin. 1998 Fall;62(4 Suppl A):A65-81. Review.

PMID:
9810778
11.

Behavior therapy for obsessive compulsive disorder.

Greist JH.

J Clin Psychiatry. 1994 Oct;55 Suppl:60-8. Review.

PMID:
7961534
12.

An integrated approach to treatment of obsessive compulsive disorder.

Greist JH.

J Clin Psychiatry. 1992 Apr;53 Suppl:38-41. Review.

PMID:
1532963
13.

[Behavior psychotherapy in obsessive-compulsive disorders].

Marks IM.

Encephale. 1990 Jul-Aug;16 Spec No:341-6. French.

PMID:
2209493
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk